Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05510297 · ClinicalTrials.gov registry record · NA
Active Seating System to Lessen Sedentariness in Older Adults: In-home Testing Phase
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05510297 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 17 participants.
The verdict
NCT05510297, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
FitSitt is an innovative device tailored to older adults that increases the convenience of breaking up sedentary activity and incorporating physical activity into in-home daily routines. This comprehensive seating solution merges features of a posture chair, exercise machine, rehabilitation tool, and activity tracker. Its primary purpose is to reduce daily immobile time, offering users a convenient means for replacing sedentary bouts with varying intensities of physical activity, ultimately leading to improved health. FitSitt aims to improve the baseline activity profile of its users by providing a comprehensive wellness solution including a non-disruptive in-home means for physical activity engagement while allowing users to continue participation in desired seated activities. In so doing, FitSitt has the potential to decrease health-harmful sedentary activity in a wide variety of high-risk individuals and occupational contexts. The initial development of FitSitt for this Phase I proposal, however, will target community-dwelling older adults. Co-led by Activ Sitting, Inc. and USC, Phase I will include three study phases (i.e., focus group, in-lab testing, in-home testing) to determine user acceptability, feasibility of procedures, safety, and preliminary efficacy to affect health and behavior outcomes. Clinical trial activities occur within the in-home testing stage and will focus on user acceptability and preliminary efficacy to affect health and behavioral outcomes. This information will be used along with other information collected from the overall study to redesign and enhance the current FitSitt prototype and prepare the system to be tested in a fully powered Phase II study of the enhanced FitSitt's efficacy to improve health in community-living older people. As currently designed, FitSitt provides convenience, comfort, and health value-add for myriad older adults, ensuring scalability and sustainability of broad use across communities and markets. This proj
Interventions
- DEVICE FitSitt Prototype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2024-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05510297
The ClinicalTrials.gov registry entry for NCT05510297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FitSitt Prototype is the first listed.
NCT05510297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05510297 about?
NCT05510297 is a clinical study titled "Active Seating System to Lessen Sedentariness in Older Adults: In-home Testing Phase". FitSitt is an innovative device tailored to older adults that increases the convenience of breaking up sedentary activity and incorporating physical activity into in-home daily routines. This comprehensive seating solution merges features of a posture chair, exercise machine, rehabilitation tool, an...
What is the current status of trial NCT05510297?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-09-27. Estimated completion is 2024-03-18.
What interventions are being tested in trial NCT05510297?
The interventions under investigation include: FitSitt Prototype (DEVICE).
Who is sponsoring clinical trial NCT05510297?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.